Life Spine Receives FDA Clearance of PRO-LINK Ti Standalone Cervical Spacer

Life Spine received FDA 510(k) clearance to market the PRO-LINK® Ti Standalone Cervical Spacer. Full launch is scheduled for the end of 4Q16.

PRO-LINK Ti features the Osseo-Loc™ proprietary surface treatment for titanium with 500 to 600 microns of porosity to support bone growth. The implant includes lateral graft windows to enhance bone graft...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us